Margaret Olinger

Insider Reports History

Entity
Individual
Location
C/O Amylyx Pharmaceuticals, Inc., 43 Thorndike Street, Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Margaret Olinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 276K $5.18M $18.76 Dec 27, 2023 Direct
Amylyx Pharmaceuticals, Inc. Chief Commercial Officer Stock Option (Right to Buy) 44.6K Dec 27, 2023 Direct

Insider Reports Filed by Margaret Olinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMLX Amylyx Pharmaceuticals, Inc. Dec 27, 2023 2 $9.25K 4 Dec 29, 2023 Chief Commercial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jul 12, 2023 2 $7.4K 4 Jul 14, 2023 Chief Commercial Officer
AMLX Amylyx Pharmaceuticals, Inc. May 22, 2023 1 $0 4 May 24, 2023 Chief Commercial Officer
AMLX Amylyx Pharmaceuticals, Inc. Mar 16, 2023 2 $0 4 Mar 20, 2023 Chief Commercial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2023 2 $87.2K 4 Jan 10, 2023 Chief Commercial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 3 $130K 4 Jan 10, 2022 Chief Commercial Officer
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Chief Commercial Officer